DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor
暂无分享,去创建一个
W. Foulkes | D. Rakheja | J. Nowak | T. Laetsch | K. Janeway | P. Meyers | R. Pinches | Catherine M. Clinton | S. Vargas | S. DuBois | J. Schienda | D. Weiser | Vera A Paulson | D. Shulman | J. Kamihara | E. Mullen | M. Breen | K. Schultz | M. Schoettler | A. Church | Deirdre Reidy | Abigail Ward | R. S. Pinches | Vera A. Paulson
[1] Ryan J. Schmidt,et al. Expanding the spectrum of dicer1-associated sarcomas , 2019, Modern Pathology.
[2] K. Ichimura,et al. Two cases of primary supratentorial intracranial rhabdomyosarcoma with DICER1 mutation which may belong to a “spindle cell sarcoma with rhabdomyosarcoma-like feature, DICER1 mutant” , 2019, Brain Tumor Pathology.
[3] Angad P. Singh,et al. Germline DICER1‐mutant intracranial sarcoma with dual chondroid and spindle cell morphology and pulmonary metastases treated with multimodal therapy , 2019, Pediatric blood & cancer.
[4] W. Foulkes,et al. An update on the central nervous system manifestations of DICER1 syndrome , 2019, Acta Neuropathologica.
[5] David T. W. Jones,et al. Primary intracranial sarcomas with DICER1 mutation often contain prominent eosinophilic cytoplasmic globules and can occur in the setting of neurofibromatosis type 1 , 2019, Acta Neuropathologica.
[6] M. Kool,et al. ETMR-like infantile cerebellar embryonal tumors in the extended morphologic spectrum of DICER1-related tumors , 2018, Acta Neuropathologica.
[7] Isabelle Salmon,et al. Methods of measurement for tumor mutational burden in tumor tissue. , 2018, Translational lung cancer research.
[8] David T. W. Jones,et al. Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations , 2018, Acta Neuropathologica.
[9] S. Bens,et al. Multiple DICER1‐related tumors in a child with a large interstitial 14q32 deletion , 2018, Genes, chromosomes & cancer.
[10] Gretchen M. Williams,et al. DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies , 2018, Clinical Cancer Research.
[11] Gretchen M. Williams,et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: a unique variant of the two-hit tumor suppression model , 2018, F1000Research.
[12] K. Cole,et al. Comprehensive Analysis of Hypermutation in Human Cancer , 2017, Cell.
[13] P. Stephens,et al. Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers , 2017, Molecular Cancer Therapeutics.
[14] Jeffrey K. Mito,et al. Role of Histone H3K27 Trimethylation Loss as a Marker for Malignant Peripheral Nerve Sheath Tumor in Fine-Needle Aspiration and Small Biopsy Specimens , 2017, American journal of clinical pathology.
[15] J. Ragoussis,et al. Sequencing of DICER1 in sarcomas identifies biallelic somatic DICER1 mutations in an adult-onset embryonal rhabdomyosarcoma , 2017, British Journal of Cancer.
[16] Levi Garraway,et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.
[17] L. Macconaill,et al. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. , 2017, Archives of pathology & laboratory medicine.
[18] Marian Harris,et al. Institutional implementation of clinical tumor profiling on an unselected cancer population. , 2016, JCI insight.
[19] Gretchen M. Williams,et al. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model. , 2015, F1000Research.
[20] M. Gullerová,et al. Swiss army knives: non-canonical functions of nuclear Drosha and Dicer , 2015, Nature Reviews Molecular Cell Biology.
[21] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[22] J. Wolchok,et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.
[23] W. Foulkes,et al. DICER1: mutations, microRNAs and mechanisms , 2014, Nature Reviews Cancer.
[24] J. Lupski,et al. Germ-line and somatic DICER1 mutations in pineoblastoma , 2014, Acta Neuropathologica.
[25] Trevor J Pugh,et al. Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences , 2014, Oncogene.
[26] P. Maeder,et al. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations , 2014, Acta Neuropathologica.
[27] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[28] Arjun Bhutkar,et al. In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs. , 2012, RNA.
[29] Gretchen M. Williams,et al. DICER1 Mutations in Familial Pleuropulmonary Blastoma , 2009, Science.
[30] S. Friend,et al. Pleuropulmonary blastoma: A marker for familial disease , 1996 .
[31] T. Arndt,et al. In vivo , 2019, Springer Reference Medizin.
[32] M. O'sullivan,et al. Anaplastic sarcomas of the kidney are characterized by DICER1 mutations , 2018, Modern Pathology.
[33] Marilyn M. Li,et al. Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. , 2017, The Journal of molecular diagnostics : JMD.
[34] S. Ogino,et al. Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing. , 2017, The Journal of molecular diagnostics : JMD.
[35] C. Fletcher,et al. Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics , 2016, Modern Pathology.